Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction (2013)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - FMRP ; JORDAO JUNIOR, ALCEU AFONSO - FMRP ; TUCCI JUNIOR, SILVIO - FMRP ; MARTINS, ANTONIO CARLOS PEREIRA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00210-013-0882-z
- Subjects: DISFUNÇÃO ERÉTIL; ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2013
- Source:
- Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology
- ISSN: 0028-1298
- Volume/Número/Paginação/Ano: v. 386, n. 9, p. 805-811, 2013
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
MUNIZ, Jaqueline J. et al. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 386, n. 9, p. 805-811, 2013Tradução . . Disponível em: https://doi.org/10.1007/s00210-013-0882-z. Acesso em: 19 abr. 2024. -
APA
Muniz, J. J., Lacchini, R., Sertório, J. T. C., Jordão Júnior, A. A., Nobre, Y. T. D. A., Tucci Júnior, S., et al. (2013). Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction. Naunyn-Schmiedeberg's Archives of Pharmacology, 386( 9), 805-811. doi:10.1007/s00210-013-0882-z -
NLM
Muniz JJ, Lacchini R, Sertório JTC, Jordão Júnior AA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 9): 805-811.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00210-013-0882-z -
Vancouver
Muniz JJ, Lacchini R, Sertório JTC, Jordão Júnior AA, Nobre YTDA, Tucci Júnior S, Martins ACP, Tanus-Santos JE. Low nitric oxide bioavailability is associated with better responses to sildenafil in patients with erectile dysfunction [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2013 ; 386( 9): 805-811.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00210-013-0882-z - Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
- Comparative assessment of circulating matrix metalloproteinases and their endogenous inhibitors in erectile dysfunction
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
Informações sobre o DOI: 10.1007/s00210-013-0882-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas